Compounds > yh 439

Page last updated: 2024-09-04

yh 439 and 2,3,7,8-tetrachlorodibenzodioxine

yh 439 has been researched along with 2,3,7,8-tetrachlorodibenzodioxine in 1 studies

Compound Research Comparison

Studies (yh 439)	Trials (yh 439)	Recent Studies (post-2010) (yh 439)	Studies (2,3,7,8-tetrachlorodibenzodioxine)	Trials (2,3,7,8-tetrachlorodibenzodioxine)	Recent Studies (post-2010) (2,3,7,8-tetrachlorodibenzodioxine)
21	0	2	15	0	6

Protein Interaction Comparison

Protein	Taxonomy	yh 439 (IC50)	2,3,7,8-tetrachlorodibenzodioxine (IC50)
Vascular endothelial growth factor receptor 1	Homo sapiens (human)		0.0027

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Antonchick, AP; Brause, A; Dötsch, L; Flegel, A; Flegel, J; Hoffmann, JE; Janning, P; Jia, ZJ; Krzyzanowski, A; Lian, Y; Metz, M; Moura-Alves, P; Rastinejad, F; Reich, A; Schade, D; Scheel, R; Schneidewind, T; Schulte, B; Shaaban, S; Sievers, S; Stender, ID; Strohmann, C; Waldmann, H; Wesseler, F; Xue, G; Zhang, M; Ziegler, S	1

Other Studies

1 other study(ies) available for yh 439 and 2,3,7,8-tetrachlorodibenzodioxine

Article	Year
The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast Differentiation. Journal of medicinal chemistry, 2022, 12-22, Volume: 65, Issue:24 Topics: Cell Differentiation; Hedgehog Proteins; Osteoblasts; Receptors, Aryl Hydrocarbon; Signal Transduction	2022